Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

4-Hydroxyglutamate is a novel predictor of pre-eclampsia

13 May 2019

Abstract excerpt

BACKGROUND: Pre-term pre-eclampsia is a major cause of maternal and perinatal morbidity and mortality worldwide. A multi-centre randomized-controlled trial has shown that first-trimester screening followed by treatment of high-risk women with aspirin reduces the risk of pre-term pre-eclampsia. However, the biomarkers currently employed in risk prediction are only weakly associated with the outcome. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gestational Diabetes Research and Management
Share to Pregnancy and preeclampsia studies
Share to Preterm Birth and Chorioamnionitis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31098639
DOI: 10.1093/ije/dyz098

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

4-Hydroxyglutamate is a novel predictor of pre-eclampsiaPMID 31098639Read ↗

Association between human blood metabolome and the risk of pre-eclampsia.Semantic proximity Read ↗

Novel biomarkers for pre-eclampsia detected using metabolomics and machine learningSemantic proximity Read ↗

Machine Learning-Driven Early Prediction of Spontaneous Preterm Birth Subtypes from Second-Trimester Plasma MetabolomicSemantic proximity Read ↗

Postpartum plasma metabolomic profile among women with preeclampsia and preterm delivery: implications for long-term healthSemantic proximity Read ↗

First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics ApproachSemantic proximity Read ↗

Metabolic Dynamics and Prediction of Gestational Age and Time to Delivery in Pregnant WomenSemantic proximity Read ↗

Plasma metabolites are altered before and after diagnosis of preeclampsia or fetal growth restrictionSemantic proximity Read ↗

Untargeted metabolomics: an overview of its usefulness and future potential in prenatal diagnosisSemantic proximity Read ↗

Diagnosis of preeclampsia using metabolomic biomarkersSemantic proximity Read ↗

Urinary metabolic profiles in early pregnancy are associated with preterm birth and fetal growth restriction in the Rhea mother–child cohort studySemantic proximity Read ↗

Metabolic profiling of maternal serum of women at high-risk of spontaneous preterm birth using NMR and MGWAS approach.Semantic proximity Read ↗

Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restrictionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.